Literature DB >> 29593867

Joint hierarchical Gaussian process model with application to personalized prediction in medical monitoring.

Leo L Duan1, Xia Wang2, John P Clancy3, Rhonda D Szczesniak4.   

Abstract

A two-level Gaussian process (GP) joint model is proposed to improve personalized prediction of medical monitoring data. The proposed model is applied to jointly analyze multiple longitudinal biomedical outcomes, including continuous measurements and binary outcomes, to achieve better prediction in disease progression. At the population level of the hierarchy, two independent GPs are used to capture the nonlinear trends in both the continuous biomedical marker and the binary outcome, respectively; at the individual level, a third GP, which is shared by the longitudinal measurement model and the longitudinal binary model, induces the correlation between these two model components and strengthens information borrowing across individuals. The proposed model is particularly advantageous in personalized prediction. It is applied to the motivating clinical data on cystic fibrosis disease progression, for which lung function measurements and onset of acute respiratory events are monitored jointly throughout each patient's clinical course. The results from both the simulation studies and the cystic fibrosis data application suggest that the inclusion of the shared individual-level GPs under the joint model framework leads to important improvements in personalized disease progression prediction.

Entities:  

Keywords:  bayesian methods; biostatistics; forecasting; longitudinal data; prediction; regression

Year:  2018        PMID: 29593867      PMCID: PMC5868980          DOI: 10.1002/sta4.178

Source DB:  PubMed          Journal:  Stat (Int Stat Inst)        ISSN: 2049-1573


  16 in total

1.  Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

Authors:  Michael W Konstan; Wayne J Morgan; Steven M Butler; David J Pasta; Marcia L Craib; Stefanie J Silva; Dennis C Stokes; Mary Ellen B Wohl; Jeffrey S Wagener; Warren E Regelmann; Charles A Johnson
Journal:  J Pediatr       Date:  2007-06-22       Impact factor: 4.406

2.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

3.  Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.

Authors:  Don B Sanders; Rachel C L Bittner; Margaret Rosenfeld; Lucas R Hoffman; Gregory J Redding; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

4.  Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood.

Authors:  Rhonda D Szczesniak; Dan Li; Weiji Su; Cole Brokamp; John Pestian; Michael Seid; John P Clancy
Journal:  Am J Respir Crit Care Med       Date:  2017-08-15       Impact factor: 21.405

5.  Real-time individual predictions of prostate cancer recurrence using joint models.

Authors:  Jeremy M G Taylor; Yongseok Park; Donna P Ankerst; Cecile Proust-Lima; Scott Williams; Larry Kestin; Kyoungwha Bae; Tom Pickles; Howard Sandler
Journal:  Biometrics       Date:  2013-02-04       Impact factor: 2.571

6.  Efficient Gaussian process regression for large datasets.

Authors:  Anjishnu Banerjee; David B Dunson; Surya T Tokdar
Journal:  Biometrika       Date:  2013-03       Impact factor: 2.445

7.  A semiparametric approach to estimate rapid lung function decline in cystic fibrosis.

Authors:  Rhonda D Szczesniak; Gary L McPhail; Leo L Duan; Maurizio Macaluso; Raouf S Amin; John P Clancy
Journal:  Ann Epidemiol       Date:  2013-10-05       Impact factor: 3.797

8.  A comparison of change point models with application to longitudinal lung function measurements in children with cystic fibrosis.

Authors:  Angela Moss; E Juarez-Colunga; Farouk Nathoo; Brandie Wagner; Scott Sagel
Journal:  Stat Med       Date:  2016-01-05       Impact factor: 2.373

9.  Predicting future lung function decline in cystic fibrosis patients: Statistical methods and clinical connections.

Authors:  Rhonda D Szczesniak; Gary L McPhail; Dan Li; Raouf S Amin; John P Clancy
Journal:  Pediatr Pulmonol       Date:  2015-12-17

10.  Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study.

Authors:  David Taylor-Robinson; Margaret Whitehead; Finn Diderichsen; Hanne Vebert Olesen; Tania Pressler; Rosalind L Smyth; Peter Diggle
Journal:  Thorax       Date:  2012-05-03       Impact factor: 9.139

View more
  3 in total

1.  Flexible link functions in a joint hierarchical Gaussian process model.

Authors:  Weiji Su; Xia Wang; Rhonda D Szczesniak
Journal:  Biometrics       Date:  2020-05-28       Impact factor: 1.701

2.  Risk factor identification in cystic fibrosis by flexible hierarchical joint models.

Authors:  Weiji Su; Xia Wang; Rhonda D Szczesniak
Journal:  Stat Methods Med Res       Date:  2020-08-25       Impact factor: 3.021

Review 3.  Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods.

Authors:  Lucy M Bull; Mark Lunt; Glen P Martin; Kimme Hyrich; Jamie C Sergeant
Journal:  Diagn Progn Res       Date:  2020-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.